True Blueberry

Blueberry Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for common skin and nail conditions. The company utilizes a proprietary nanodelivery platform to enhance the penetration and efficacy of well-characterized active pharmaceutical ingredients, particularly for dermatological and podiatric indications. Its lead program, BBT-001, is a topical antifungal treatment for onychomycosis designed to provide superior nail plate penetration compared to existing therapies. By focusing on high-prevalence conditions with significant unmet needs, Blueberry Therapeutics aims to deliver safer and more effective treatments for patients worldwide.